Description:NebuSelect™ Recombinant Human IL-20RA, hFc-tag(Cat#NBL-242487) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Val30-Lys250.

Species:Human

Expression System:HEK293

Molecular Weight: The protein has a predicted MW of 52 kDa. Due to glycosylation, the protein migrates to 65-70 kDa based on Bis-Tris PAGE result.

Target Name:IL-20RASynonymsIL-20R-alpha; IL-20RA; CRF2-8; IL-20R1; ZcytoR7; FLJ40993

Target Information:IL-20RA was highly expressed in the tumor tissue of CRC and related to the advanced stage.IL-20RA was involved in regulating oncogenic and immune pathways and affecting the expression of genes related to cell proliferation and immune evasion in CRC.Super-enhancer inhibition by JQ-1 or iBET-151 suppressed the growth of tumor cells and inhibited the expression of IL-20RA.

Amino Acid Sequence: Val30-Lys250

Purity:＞95%

Endotoxin:＜1EU/ug(LAL Method)